‘Leaner, More Focused’: Purdue Pharma Shifts Focus To Opioid Litigation As Revenues Drop To Record Lows, Workforce Declines

Purde Pharma, which is considering filing for bankruptcy, had been earning $3 billion a year and employed nearly 2,000 employees. Sales have declined and last year the company eliminated its sales force as 1,800 lawsuits against the OxyContin-maker allege it started the opioid epidemic. News on the crisis focuses on dangers to opioid-exposed children, revisions to treatment strategies, monitoring prescriptions and help for jailed sufferers, as well.

from Kaiser Health News https://ift.tt/2LsnugF